Ondansetron and Metformin-Induced Gastrointestinal Side Effects

No abstract is available for this paper.

• Publication year

  2003

• Venue

  American Journal of Therapeutics

• Publication date

  2003-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00045391-200311000-00012PMID 14624284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

  2002cited by this paper
• Neuropharmacology of 5-HT3 Receptor Ligands

  2000cited by this paper
• Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors

  1999influential reference
• Autoreceptors can modulate 5-hydroxytryptamine release from porcine and human small intestine in vitro

  1998cited by this paper
• Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

  1998cited by this paper
• Antiemetic activity of ondansetron in acute gastroenteritis

  1997cited by this paper
• A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy.

  1996cited by this paper
• New oral agents for type II diabetes. Taking a more aggressive approach to therapy.

  1995cited by this paper
• Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

  1995cited by this paper
• Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies.

  1995cited by this paper
• Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy.

  1995cited by this paper
• New oral agents for type II diabetes.

  1995cited by this paper
• Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis.

  1995cited by this paper
• Functional colonic and anorectal disorders.

  1995cited by this paper
• Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Comparative Tolerability Profiles of Oral Antidiabetic Agents

  1994cited by this paper
• Treatment of chronic cryptosporidiosis-induced diarrhea with a serotonin receptor antagonist.

  1994cited by this paper
• Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine

  1993cited by this paper
• Mechanisms of vomiting induced by serotonin-3 receptor agonists in the cat: effect of vagotomy, splanchnicectomy or area postrema lesion.

  1992cited by this paper
• Biguanides and NIDDM

  1992cited by this paper
• Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs.

  1992cited by this paper
• The agonist properties of m‐chlorophenylbiguanide and 2‐methyl‐5‐hydroxytryptamine on 5‐HT3 receptors in N1E‐115 neuroblastoma cells

  1991cited by this paper
• Cisplatin increases the release of 5-hydroxytryptamine (5-HT) from the isolated vascularly perfused small intestine of the guinea-pig: Involvement of 5-HT3 receptors

  1991cited by this paper
• 1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist.

  1990cited by this paper
• Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.

  1990cited by this paper
• The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret.

  1988cited by this paper
• Diarrhea and Metformin in a Diabetic Clinic

  1983cited by this paper
• Relative activities of substances related to 5-hydroxytryptamine as depolarizing agents of superior cervical ganglion cells.

  1981cited by this paper

• Sodium Alginate–Starch Capsules for Enhanced Stability of Metformin in Simulated Gastrointestinal Fluids

  2024cites this paper
• A review on biogenic silver nanoparticles as efficient and effective antidiabetic agents

  2023cites this paper
• Repurposing Metformin in hematologic tumor: State of art.

  2023cites this paper
• Mitochondria as an important target of metformin: the mechanism of action, toxic and side effects, and new therapeutic applications.

  2022cites this paper
• Thymus serpyllum Exhibits Anti-Diabetic Potential in Streptozotocin-Induced Diabetes Mellitus Type 2 Mice: A Combined Biochemical and In Vivo Study

  2022cites this paper
• Oral Antidiabetics and Sleep Among Type 2 Diabetes Patients: Data From the UK Biobank

  2021cites this paper
• Galactomannan Restore Letrozole Induced Polycystic Ovarian Syndrome (PCOS) in Rat Model

  2021cites this paper
• Combination of Oligofructose and Metformin Alters the Gut Microbiota and Improves Metabolic Profiles, Contributing to the Potentiated Therapeutic Effects on Diet-Induced Obese Animals

  2020cites this paper
• Effect of Zingiber officinale and Nigella sativa on Streptozotocin-Diabetic Rats with Reference to Biochemical and Hematological Studies

  2020cites this paper
• Mouse model of metformin-induced diarrhea

  2020cites this paper
• Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

  2019cites this paper
• Metformin induces weight loss associated with gut microbiota alteration in non-diabetic obese women: a randomized double-blind clinical trial.

  2019cites this paper
• Blood Sugar Lowering Effect of Stem Part of Berberis aristata as add on Therapy in Type-2 Diabetes Mellitus Patients

  2018cites this paper
• Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in diabetic patients with dyslipidemia

  2018cites this paper
• Association of metformin administration with gut microbiome dysbiosis in healthy volunteers

  2018cites this paper
• Casein glycomacropeptide hydrolysates ameliorate hepatic insulin resistance of C57BL/6J mice challenged with high-fat diet

  2018cites this paper
• Ginkgolide A ameliorates non-alcoholic fatty liver diseases on high fat diet mice.

  2017cites this paper
• Metformin – újabb adatok egy megbízható és hatékony „régi” vércukorcsökkentő készítményről

  2016cites this paper
• Efficacy and Safety of Linagliptin Co-Administered with Low-Dose Metformin Once Daily Versus High-Dose Metformin Twice Daily in Treatment-Naïve Patients with Type 2 Diabetes: a Double-Blind Randomized Trial

  2015cites this paper
• From molecule to men: Inhibition of intestinal glucose absorption by polyphenols and plant extracts for reducing the glycemic response

  2014cites this paper
• Interplay between metformin and serotonin transport in the gastrointestinal tract: A novel mechanism for the intestinal absorption and adverse effects of metformin

  2013cites this paper
• Jiaotai pill (交泰丸) enhances insulin signaling through phosphatidylinositol 3-kinase pathway in skeletal muscle of diabetic rats

  2013cites this paper
• Effect of Emulin on Blood Glucose in Type 2 Diabetics

  2013cites this paper
• Investigating the effect of emetic and aversive compounds on Dictyostelium identifies a novel non-sentient model for bitter tastant research

  2013cites this paper
• Aloe barbadensis Mill. formulation restores lipid profile to normal in a letrozole-induced polycystic ovarian syndrome rat model

  2012cites this paper
• Silk fibroin hydrolysate exerts an anti-diabetic effect by increasing pancreatic β cell mass in C57BL/KsJ-db/db mice

  2012cites this paper
• Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis

  2012cites this paper
• Investigating the Effect of Emetic Compounds on Chemotaxis in Dictyostelium Identifies a Non-Sentient Model for Bitter and Hot Tastant Research

  2011cites this paper
• Metformin and digestive disorders.

  2011cites this paper
• Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis

  2011cites this paper
• Impact of Metformin-Induced Gastrointestinal Symptoms on Quality of Life and Adherence in Patients with Type 2 Diabetes

  2010cites this paper
• Gastrointestinal and Hepatic Manifestations of Systemic Diseases

  2010cites this paper
• Impact of Metformin on Immunity and Male Fertility in Rabbits with Alloxan-Induced Diabetes

  2010cites this paper
• Bowel motions in critically ill patients: a pilot observational study.

  2010cites this paper
• Opportunities for the replacement of animals in the study of nausea and vomiting

  2009cites this paper
• Less is more: reducing the reliance on animal models for nausea and vomiting research

  2009cites this paper
• Gastrointestinal Syndromes Due to Diabetes Mellitus

  2007cites this paper
• Clinical Pharmacology: Advances and Applications Dovepress

  year unknowncites this paper